Activation and release of degradative proteinases within the myocardium are the trigger for ventricular remodeling in

J D Sackner-Bernstein1

  • 1Division of Cardiology, St Luke's-Roosevelt Hospital Center, New York, NY 10025, USA. jsackner-bernstein@slrhc.org

Medical Hypotheses
|February 28, 2002
PubMed

Insights

Chronic heart failure is better explained by an expanded model focusing on myocardial matrix events, integrating the neurohormonal system, immune system, and fibroblasts. This approach addresses limitations of the current neurohormonal model in heart failure pathophysiology.

Area of Science:

  • Cardiology
  • Pathophysiology
  • Biomedical Engineering

Background:

  • The current neurohormonal model explains chronic heart failure (CHF) by persistent activation of homeostasis systems post-myocardial injury.
  • This model, however, does not fully elucidate triggers for neurohormone release or ventricular dysfunction without significant myocardial infarction.

Purpose of the Study:

  • To address limitations in the current neurohormonal model of CHF.
  • To propose an expanded conceptual framework for understanding CHF pathophysiology.

Main Methods:

  • The study reviews existing literature on CHF pathophysiology.
  • It proposes a conceptual framework integrating the neurohormonal model with myocardial matrix events, immune system, and fibroblast roles.

Main Results:

  • The proposed expanded model incorporates myocardial matrix events as key triggers for disease progression.
  • It integrates the roles of the immune system and myocardial fibroblasts in the context of the matrix.

Conclusions:

  • An expanded model focusing on myocardial matrix events, immune system, and fibroblasts offers a more comprehensive understanding of CHF initiation and progression.
  • This framework addresses gaps in the current neurohormonal model, providing a more complete picture of heart failure pathophysiology.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...